DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

B. C. M. Hermans, J. L. Derks, E. Thunnissen, R. J. van Suylen, M. A. den Bakker, H. J. M. Groen, E. F. Smit, R. A. Damhuis, E. C. van den Broek, A. Ruland, E. J. M. Speel, A. M. C. Dingemans*,

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)102-108
Number of pages7
JournalLung Cancer
Volume138
DOIs
Publication statusPublished - Dec 2019

Keywords

  • Large cell neuroendocrine carcinoma (LCNEC)
  • Lung cancer
  • DLL3
  • ASCL1
  • RB1
  • DELTA-LIKE 3
  • ANTIBODY-DRUG CONJUGATE
  • LUNG-CANCER
  • CHEMOTHERAPY
  • TESIRINE
  • THERAPY

Cite this